Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic

Last updated: May 18, 2016

CMS Measure ID: CMS164v3
Version: 3
NQF Number: 0068
Measure Description:

Percentage of patients 18 years of age and older who were discharged alive for acute myocardial infarction (AMI), coronary artery bypass graft (CABG) or percutaneous coronary interventions (PCI) in the 12 months prior to the measurement period, or who had an active diagnosis of ischemic vascular disease (IVD) during the measurement period, and who had documentation of use of aspirin or another antithrombotic during the measurement period.

Initial Patient Population:

Patients 18 years of age and older with a visit during the measurement period, and an active diagnosis of ischemic vascular disease (IVD) or who were discharged alive for acute myocardial infarction (AMI), coronary artery bypass graft (CABG) or percutaneous coronary interventions (PCI) in the 12 months prior to the measurement period

Denominator Statement:

Equals Initial Patient Population

Denominator Exclusions:

Not Applicable

Numerator Statement:

Patients who have documentation of use of aspirin or another antithrombotic during the measurement period

Numerator Exclusions:

Not Applicable

Denominator Exceptions:

None

Measure Steward: National Committee for Quality Assurance
National Quality Strategy Domain: Effective Clinical Care
Next Version: Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic
Measure Score: Proportion
Score Type: Process
Improvement Notation:

Higher score indicates better quality

Guidance:

Only patients who were discharged alive for acute myocardial infarction (AMI), coronary artery bypass graft (CABG) or percutaneous coronary interventions (PCI) should be included in the measure.

Specifications

External Resources